Evozyne

Evozyne is a Chicago-based biotechnology company APPlying deep learning to protein engineering. Rather than relying solely on random mutagenesis or exhaustive laboratory screening, the company trAIns models that propose novel protein sequences with desired functional pRoPErties. The approach treats evolution as a design resource: machine-learning models explore enormous sequence spaces and surface candidates that would be imprACTical to find by trial alone, which the team then validates experimentally in its laboratory.

What it does

The core ideas are generative protein design and data-driven fitness prediction. Models learn from protein sequence and functional data and generate candidate variants predicted to perform better in a target application. Evozyne focuses on functional proteins rather than just structure prediction, aiming for designs that work in real assays and can move toward commercial use.

Key capabilities

• Generative sequence design: proposing new protein sequences rather than only scoring existing ones.
• Property optimization: steering designs toward attributes such as activity, stability, or manufacturability.
• Experimental validation: testing computational predictions with wet-lab assays to close the design-build-test loop.
• Application focus: therapeutic proteins and enzymes relevant to sustainability and industrial processes.
• Cross-disciplinary teams: machine learning, protein science, and laboratory research working together.

Because many details are company-specific and not public, the exact model architectures, datasets, and success rates may vary and should be treated with caution.

Who it is for

Evozyne's offering is primarily business-to-business and research-oriented. PhArmaceutical and biotech partners exploring enzyme or protein therapeutics, industrial bioTechnology companies looking for improved biocatalysts, and academic collaborators in protein engineering are plausible audiences. IndiVidual developers or casual users looking for a ready-made protein design tool are less likely to find a self-serve product; most collaboration likely begins through direct contact or partnership discussions.

How to get started

1. Visit the company's official site to review its published research and application areas.
2. Identify whether your project matches its therapeutic or sustainability focus.
3. Reach out through the contact Information provided on the site for Partnership or research inquiries.
4. Expect an evaluation process; access to models and data is likely negotiated rather than instantly available.

Pricing and access caveat

Pricing is not publicly documented and may depend on the scope of a partnership or licensing agreement. There may be no open self-service tier, and model availability, data access, and terms can change. Treat any figures you encounter as unverified until confirmed directly with the company.